Stay updated on Pembrolizumab in Refractory Meningioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Refractory Meningioma Clinical Trial page

  1. Check
    8 days ago
    Change Detected
    Summary
    Revision updated to v3.3.4, replacing the previous v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T03:14:59.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T20:40:58.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    A new revision label 'v3.3.2' appears, replacing 'v3.2.0', indicating a site version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:43:46.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Removed the generic government funding and operating status notice from the page; study details and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:53:32.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    No changes detected; the two screenshots show the same study details page.
    Difference
    0.4%
    Check dated 2025-11-03T20:41:24.000Z thumbnail image
  8. Check
    108 days ago
    Change Detected
    Summary
    - Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:57:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Refractory Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.